These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 12124943)

  • 1. Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice.
    Lécureuil C; Fontaine I; Crepieux P; Guillou F
    Genesis; 2002 Jul; 33(3):114-8. PubMed ID: 12124943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the fate of Sry-expressing cells using an in vivo Cre/loxP system.
    Ito M; Yokouchi K; Yoshida K; Kano K; Naito K; Miyazaki J; Tojo H
    Dev Growth Differ; 2006 Jan; 48(1):41-7. PubMed ID: 16466392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin alpha-iCre mice: Cre deleter lines for the gonads, pituitary, and adrenal.
    Jorgez CJ; De Mayo FJ; Matzuk MM
    Genesis; 2006 Apr; 44(4):183-8. PubMed ID: 16604527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice.
    Xin HB; Deng KY; Rishniw M; Ji G; Kotlikoff MI
    Physiol Genomics; 2002 Sep; 10(3):211-5. PubMed ID: 12209023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of keratinocyte-specific Cre recombinase transgenic mice].
    Mao CM; Yang X; Cheng X; Lü YX; Zhou J; Huang CF
    Yi Chuan Xue Bao; 2003 May; 30(5):407-13. PubMed ID: 12924153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A transgenic mouse that targets the expression of Cre recombinase in hepatocyte].
    Wang YL; Cheng X; Cui F; Cheng J; Lü YX; Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):163-6. PubMed ID: 15059303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thick ascending limb-specific expression of Cre recombinase.
    Stricklett PK; Taylor D; Nelson RD; Kohan DE
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F33-9. PubMed ID: 12644440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrocyte-specific expression of Cre recombinase in transgenic mice.
    Kusakabe T; Kawaguchi A; Kawaguchi R; Feigenbaum L; Kimura S
    Genesis; 2004 Jul; 39(3):212-6. PubMed ID: 15282748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
    Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
    Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte-specific expression of cre recombinase in transgenic mice.
    Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
    Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
    Zhou J; Cheng X; Lu YX; Huang CF; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flp recombinase transgenic mice of C57BL/6 strain for conditional gene targeting.
    Takeuchi T; Nomura T; Tsujita M; Suzuki M; Fuse T; Mori H; Mishina M
    Biochem Biophys Res Commun; 2002 May; 293(3):953-7. PubMed ID: 12051751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
    Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
    J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seminiferous tubule degeneration and infertility in mice with sustained activation of WNT/CTNNB1 signaling in sertoli cells.
    Boyer A; Hermo L; Paquet M; Robaire B; Boerboom D
    Biol Reprod; 2008 Sep; 79(3):475-85. PubMed ID: 18480464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
    Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
    Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.